RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families

By Johnson Julie   Healey Sue   Khanna Kum   Chenevix-Trench Georgia  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer

By Sassi Agnieszka  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 451-459

Springer Publishing Company

Access to resources Recommend Favorite

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

By Musolino Antonino  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 203-205

Springer Publishing Company

Access to resources Recommend Favorite

Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite